These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 7291242)
1. Delayed emergence of antidepressant efficacy following withdrawal in olfactory bulbectomized rats. Noreika L; Pastor G; Liebman J Pharmacol Biochem Behav; 1981 Sep; 15(3):393-8. PubMed ID: 7291242 [TBL] [Abstract][Full Text] [Related]
2. Serotonin-mimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomised rats. Broekkamp CL; Garrigou D; LLoyd KG Pharmacol Biochem Behav; 1980 Nov; 13(5):643-6. PubMed ID: 6969405 [TBL] [Abstract][Full Text] [Related]
3. Olfactory bulb ablation in the rat: behavioural changes and their reversal by antidepressant drugs. van Riezen H; Schnieden H; Wren AF Br J Pharmacol; 1977 Aug; 60(4):521-8. PubMed ID: 907867 [TBL] [Abstract][Full Text] [Related]
4. Involvement of the amygdala in the effect of antidepressants on the passive avoidance deficit in bulbectomised rats. Garrigou D; Broekkamp CL; Lloyd KG Psychopharmacology (Berl); 1981; 74(1):66-70. PubMed ID: 6791207 [TBL] [Abstract][Full Text] [Related]
5. Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy. Jarosik J; Legutko B; Unsicker K; von Bohlen Und Halbach O Exp Neurol; 2007 Mar; 204(1):20-8. PubMed ID: 17059819 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of antidepressant drugs on [3H]dihydroalprenolol and [3H]imipramine ligand recognition sites in olfactory bulbectomized and sham-lesioned rats. Jesberger JA; Richardson JS Gen Pharmacol; 1986; 17(3):293-307. PubMed ID: 3013716 [TBL] [Abstract][Full Text] [Related]
8. Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats. Breuer ME; Groenink L; Oosting RS; Buerger E; Korte M; Ferger B; Olivier B Eur J Pharmacol; 2009 Aug; 616(1-3):134-40. PubMed ID: 19549514 [TBL] [Abstract][Full Text] [Related]
9. The effects of antidepressant drugs on conditioned taste aversion learning of the olfactory bulbectomized rat. Jancsár SM; Leonard BE Neuropharmacology; 1981 Dec; 20(12B):1341-5. PubMed ID: 6172744 [No Abstract] [Full Text] [Related]
10. Antidepressant-like effect of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist in the olfactory bulbectomized rats. Wieronska JM; Szewczyk B; Branski P; Palucha A; Pilc A Amino Acids; 2002; 23(1-3):213-6. PubMed ID: 12373540 [TBL] [Abstract][Full Text] [Related]
11. The effect of repeated administration of antidepressant drugs on the responsiveness of rats to catecholamine agonists. Maj J; Mogilnicka E; Klimek V J Neural Transm; 1979; 44(3):221-35. PubMed ID: 438808 [TBL] [Abstract][Full Text] [Related]
12. The olfactory bulbectomized rat as a model of depression: an update. Kelly JP; Wrynn AS; Leonard BE Pharmacol Ther; 1997; 74(3):299-316. PubMed ID: 9352586 [TBL] [Abstract][Full Text] [Related]
13. Fengabine, a novel antidepressant GABAergic agent. I. Activity in models for antidepressant drugs and psychopharmacological profile. Lloyd KG; Zivkovic B; Sanger D; Depoortere H; Bartholini G J Pharmacol Exp Ther; 1987 Apr; 241(1):245-50. PubMed ID: 3033203 [TBL] [Abstract][Full Text] [Related]
14. Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling. Buchborn T; Schröder H; Höllt V; Grecksch G J Psychopharmacol; 2014 Jun; 28(6):545-52. PubMed ID: 24785760 [TBL] [Abstract][Full Text] [Related]
15. [Behavioral pharmacological properties of the novel antidepressant paroxetine, a selective 5-HT uptake inhibitor]. Yamamoto T; Shibata S; Shimazoe T; Iwasaki K; Ohno M; Minamoto Y; Furuya Y; Miyamoto K; Watanabe S; Ueki S Nihon Yakurigaku Zasshi; 1989 Sep; 94(3):189-206. PubMed ID: 2530142 [TBL] [Abstract][Full Text] [Related]
16. A new animal model for the prediction of antidepressant activity. Wren A; van Riezen H; Rigter H Pharmakopsychiatr Neuropsychopharmakol; 1977 Mar; 10(2):96-100. PubMed ID: 616925 [TBL] [Abstract][Full Text] [Related]
17. Effects of bulbectomy and subsequent antidepressant treatment on brain 5-HT2 and 5-HT1A receptors in mice. Gurevich EV; Aleksandrova IA; Otmakhova NA; Katkov YA; Nesterova IV; Bobkova NV Pharmacol Biochem Behav; 1993 May; 45(1):65-70. PubMed ID: 8516375 [TBL] [Abstract][Full Text] [Related]
18. Effect of newly synthesized 1,2,4-triazino[5,6-b]indole-3-thione derivatives on olfactory bulbectomy induced depression in rats. Aswar UM; Kalshetti PP; Shelke SM; Bhosale SH; Bodhankar SL Asian Pac J Trop Biomed; 2012 Dec; 2(12):992-8. PubMed ID: 23593581 [TBL] [Abstract][Full Text] [Related]
19. Bupropion, d-amphetamine, and amitriptyline-induced conditioned taste aversion in rats: dose effects. Miller DB; Miller LL Pharmacol Biochem Behav; 1983 May; 18(5):737-40. PubMed ID: 6407035 [TBL] [Abstract][Full Text] [Related]
20. Influence of olfactory bulbectomy and subsequent imipramine treatment on 5-hydroxytryptaminergic presynapses in the rat frontal cortex: behavioural correlates. Grecksch G; Zhou D; Franke C; Schröder U; Sabel B; Becker A; Huether G Br J Pharmacol; 1997 Dec; 122(8):1725-31. PubMed ID: 9422820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]